Congress investigating FDA over heart device recall, says agency ‘failed to protect consumers’

Congress has opened an investigation into how the FDA handled the 2021 recall of Medtronic’s HeartWare Ventricular Assist Device (HVAD) system.

The recall, finalized on June 3, came after ongoing issues that resulted in 14 deaths and 13 pump removals. In fact, a recall of some HVAD implant kits was announced back in March 2021.

In an open letter to FDA Commissioner Robert Califf, MD—who has years of experience as a practicing cardiologistRep. Raja Krishnamoorthi said the recall “arrived too late for too many.”

Krishnamoorthi, who serves as chairman of the Subcommittee on Economic and Consumer Policy, also highlighted that the HVAD system was associated with “more than 20,000 patient injuries and 3,000 deaths” before it was recalled.

“I am concerned by FDA’s slow action, over multiple administrations, to protect patients from this product despite early warning signs,” he said.

Krishnamoorthi said the Subcommittee on Economic and Consumer Policy wants the FDA to provide more information about its actions by April 5.

“The FDA is charged with ensuring patient access to safe, effective, and high-quality medical devices, but, over multiple administrations, the agency failed to protect consumers from the dangerous HVAD System,” Krishnamoorthi wrote. “The agency likewise failed to adequately share knowledge of the device’s defects with other agencies. FDA must take a more proactive role in its regulation of devices that have been the subject of Warning Letters and Class I recalls, and in its communication of product defects to other agencies responsible for patient health.”

Medtronic issued a statement about the recall after it was first announced.

“There is nothing more important than the safety and well-being of patients,” Nnamdi Njoku, president of Medtronic’s Mechanical Circulatory Support Business, said at the time. “We recognize this information may be concerning for patients and their caregivers, and Medtronic is committed to supporting them in coordination with their physicians.”

Read the full open letter here. Additional reporting on this ongoing story from ProPublica is available here.

Related Heart Failure Content:

COVID-19 vaccines safe for patients with a history of heart damage

Medtronic stops sales and distribution of HVAD system due to multiple issues, including 14 patient deaths

FDA announces new recall of instructions for Medtronic’s HVAD system after 1 death, 64 injuries

FDA announces recall of Medtronic HVAD pump implant kits after 2 deaths, 19 serious injuries

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup